Literature DB >> 9188627

Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.

J Hinkula1, C Svanholm, S Schwartz, P Lundholm, M Brytting, G Engström, R Benthin, H Glaser, G Sutter, B Kohleisen, V Erfle, K Okuda, H Wigzell, B Wahren.   

Abstract

Mice immunized with the regulatory genes nef, rev, and tat from human immunodeficiency virus type 1 developed both humoral and cellular immune responses to the gene products Nef, Rev, and Tat. This study demonstrates that it is feasible to induce immune reactions to all of these regulatory gene products. Humoral responses were seen after DNA boosts, while potent T-cell proliferative responses were noted already after a single immunization. A Th1-directed immune response was demonstrated early after immunization. A 3- to 75-fold-stronger T-cell response was seen in animals receiving DNA epidermally compared to that in animals receiving intramuscular injections. Nef, Rev, and Tat putative B- and T-cell epitopes were clearly mapped by using peptides derived from the regulatory proteins and were similar to those which are detected in human immunodeficiency virus infection. Although immunization by the Nef, Rev, and Tat proteins raised high immunoglobulin G titers in serum, the epitope spreading appeared broader after DNA immunization. The combination of all of these regulatory genes together with two genes for structural proteins, the envelope and gag genes, demonstrated that a combined approach is feasible in that reactivities to all antigens persisted or were even augmented. No interference between plasmids was noted.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188627      PMCID: PMC191795          DOI: 10.1128/JVI.71.7.5528-5539.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Maintenance of B-cell memory by long-lived cells generated from proliferating precursors.

Authors:  B Schittek; K Rajewsky
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

2.  Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins.

Authors:  M Sällberg; U Rudén; L O Magnius; E Norrby; B Wahren
Journal:  Immunol Lett       Date:  1991-09       Impact factor: 3.685

3.  B-cell memory is short-lived in the absence of antigen.

Authors:  D Gray; H Skarvall
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

Review 4.  Use of vaccinia virus vectors for development of AIDS vaccines.

Authors:  B Moss
Journal:  AIDS       Date:  1988       Impact factor: 4.177

Review 5.  The immunobiology of muscle.

Authors:  R Hohlfeld; A G Engel
Journal:  Immunol Today       Date:  1994-06

6.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

Authors:  C C Czerkinsky; L A Nilsson; H Nygren; O Ouchterlony; A Tarkowski
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients.

Authors:  J M Sabatier; B Clerget-Raslain; G Fontan; E Fenouillet; H Rochat; C Granier; J C Gluckman; J Van Rietschoten; L Montagnier; E Bahraoui
Journal:  AIDS       Date:  1989-04       Impact factor: 4.177

8.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

9.  Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.

Authors:  T Schneider; H P Harthus; P Hildebrandt; M Niedrig; M Bröker; W Weigelt; A Beck; G Pauli
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

10.  HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.

Authors:  F Michel; A Hoffenbach; P Froussard; P Langlade-Demoyen; M Kaczorek; M P Kieny; F Plata
Journal:  AIDS Res Hum Retroviruses       Date:  1992-04       Impact factor: 2.205

View more
  8 in total

1.  Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.

Authors:  Laurent Mascarell; Catherine Fayolle; Cécile Bauche; Daniel Ladant; Claude Leclerc
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production.

Authors:  Y Asakura; L J Liu; N Shono; J Hinkula; A Kjerrström; I Aoki; K Okuda; B Wahren; J Fukushima
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

3.  Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen.

Authors:  Henry E Neuman de Vegvar; Rama Rao Amara; Lawrence Steinman; Paul J Utz; Harriet L Robinson; William H Robinson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.

Authors:  A Thermet; M Robaczewska; C Rollier; O Hantz; C Trepo; G Deleage; L Cova
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.

Authors:  Lakshmi Ramakrishna; Krishnamurthy Kumar Anand; Kumarasamypet M Mohankumar; Udaykumar Ranga
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein.

Authors:  Tracy J Ruckwardt; Ilia Tikhonov; Shannon Berg; Glen S Hatfield; Angelika Chandra; Prakash Chandra; Bruce Gilliam; Robert R Redfield; Robert C Gallo; C David Pauza
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.

Authors:  Ana María Rodríguez; María Fernanda Pascutti; Cynthia Maeto; Juliana Falivene; María Pía Holgado; Gabriela Turk; María Magdalena Gherardi
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

8.  Molecular and genetic characterization of natural HIV-1 Tat Exon-1 variants from North India and their functional implications.

Authors:  Larance Ronsard; Sneh Lata; Jyotsna Singh; Vishnampettai G Ramachandran; Shukla Das; Akhil C Banerjea
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.